A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden

Clinical trial NCT03328364 · COMPLETED

Trial details

NCT number: NCT03328364
Sponsor: Astellas Pharma a/s
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Castration Resistant Prostate Cancer

Start date: 2017-12-01
Primary completion: 2017-12-24
Enrollment: 211

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.